Navigation Links
3SBio Inc. Announces Unaudited Second Quarter Results
Date:8/17/2010

5,499 811 Grant income 187 27 187 28 Net realized gain on available-for-sale securities 1,611 236 -- -- Impairment loss on available-for-sale Securities (4,624) (677) -- -- Others 1,339 196 1,032 152 Total other (expenses)/ income, net 5,039 737 6,718 991 Income before income tax expense 50,952 7,459 62,860 9,270 Income tax expense (8,088) (1,184) (10,685) (1,576) Net income 42,864 6,275 52,175 7,694 Net income per share: Basic 0.28 0.04 0.35 0.05 Diluted 0.28 0.04 0.34 0.05 Basic weighted average number of shares outstanding 150,586,455 150,586,455 150,788,700 150,788,700 Diluted weighted average number of shares outstanding 150,694,273 150,694,273 153,878,594 153,878,594 Net income per ADS: Basic 1.99 0.29 2.42 0.36 Diluted 1.99 0.29 2.37 0.35 Basic weighted average number of ADSs outstanding 21,512,351 21,512,351 21,541,243 21,541,243 Diluted weighted average number of ADSs outstanding 21,527,753 21,527,753 21,982,656 21,982,656 Reconciliations of GAAP net income to non-GAAP net income for the first quarter of 2009 and 2010 (in RMB thousands, unaudited) Three months ended Three months ended June 30, 2009 June 30, 2010 GAAP Adjust- Non-GAAP GAAP Adjust- Non-GAAP ment ment RMB US$ RMB RMB US$ RMB US$ RMB RMB US$ Net income 26,978 3,950 (1,611) 25,367 3,714 25,524 3,764 -- 25,524 3,764 The adjustment for the three months ended June 30, 2009 is for the exclusion of the gain of RMB1, 611,000 on disposal of available-for-sale securities. Reconciliations of GAAP net income to non-GAAP net income for the first half of 2009 and 2010 (in RMB thousands, unaudited) Six months ended Six months ended June 30, 2009 June 30, 2010 GAAP Adjust- Non-GAAP GAAP Adjust- Non-GAAP ment ment RMB US$ RMB RMB US$ RMB US$ RMB RMB US$ Net income 42,864 6,275 3,013 45,877 6,716 52,175 7,694 -- 52,175 7,694 The adjustment for the six months ended June 30, 2009 is for the exclusion of the impairment loss of RMB 4,624,000 on available-for-sale securities and gain of RMB1, 611,000 on disposal of
'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. 3SBio Inc. Announces Second Quarter 2008 Results
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. 3SBio Inc. Announces Results of Annual General Meeting
5. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
6. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
7. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
8. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
9. 3SBio Inc. Files for SFDA Approval of NuLeusin
10. 3SBio Inc. Announces Third Quarter 2008 Results
11. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Freeslate, Inc ... today announced that Lupin Limited, one of India’s top ... CM Protégé PharmD System for high throughput solid ... is focused on a wide range of quality, affordable ...
(Date:1/14/2014)... 2014 Date: Friday, April 11, 2014 , ... Club, 1360 Almshouse Road, Warrington, Pa. , Details: ... dedicated to finding a cure for hepatitis B and improving ... its annual Crystal Ball on Friday, April 11 at Warrington ...
(Date:1/14/2014)... provider of strategic communications services to corporations and organizations preparing for ... United States and Europe , today ... to the firm,s Washington, D.C. office. ... years of service as Associate Commissioner for the Office of External ...
(Date:1/14/2014)... , Jan. 14, 2014 The largest ... research medicinal plants and therapeutic derivatives thereof has ... professionals, and researchers about the challenges of adulterated ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society for ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8
... 2 HUYA Bioscience,International (HUYA), a rapidly ... key disease-fighting drugs sourced from China,announced today ... stage anti-arrhythmic,compound from the prestigious Shanghai Institute ... The compound, HBI-3000 or sulcardine, exhibits ...
... Cost-Effective, Time-Saving, ATLANTA, Oct. 1 ... CliniCom(TM), a revolutionary software platform,designed to assess ... CliniCom(TM), an intuitive, computer assisted intake ... health settings, gathers information,directly from patients and ...
... Center,has awarded a five-year, $120-million extension of its ... also known,as NSBRI, of Houston. Under the extension, ... biomedical research in support of a,long-term human presence ... cooperative agreement began April 1, 1997, with,a value ...
Cached Biology Technology:HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica 2HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica 3Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology 2Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology 3
(Date:4/24/2014)... bend light, acting as a lens. Now, by exploiting ... to create inexpensive high quality lenses that will cost ... so inexpensive, the lenses can be used in a ... the field, scientific research in the lab and optical ... "What I,m really excited about is that it opens ...
(Date:4/23/2014)... heating may contribute to early fetal death according to ... Institute of Children,s Hospital Los Angeles and Ulaanbaatar, Mongolia ... In a paper published today in the journal ... statistical correlations" between seasonal ambient air pollutants and pregnancy ... one of the highest levels of air pollution of ...
(Date:4/23/2014)... news release is available in French and ... , Montreal, 23 April 2014Today, the CEC released its ... Binational Collaborative Approach to Conservation, which identifies 29 priority ... border that includes 11 different protected areas in the ... unique, highly diverse arid and semi-arid habitats inhabited by ...
Breaking Biology News(10 mins):Bake your own droplet lens 2Bake your own droplet lens 3Pollutants from coal-burning stoves strongly associated with miscarriages in Mongolia 2Conservation priorities released for several protected areas along US-Mexico border 2Conservation priorities released for several protected areas along US-Mexico border 3
... FL November 18, 2010 For Immediate Release - ... Palm Beach residents Judy and J. John Goodman, M.D., to ... Professor Thomas Kodadek, Ph.D., in the development of a new ... as the Scripps Research graduate program endowment. "We are ...
... Nov. 18, 2010 AMDeC, the Academy ... Technologies has renewed and expanded its agreement to offer ... on a number of products important for genomics and ... academic medical research institutions in the New York region. ...
... disorder characterized by progressive loss of vision that in ... stage. , In a ChIP-Seq based approach, the researchers ... Crx (Cone-rod homeobox) in the expression of retina-specific genes ... perception. In-depth analysis of Crx mediated regulation in photoreceptors ...
Cached Biology News:Agilent Technologies Expands Agreement to Offer AMDeC Members Preferential Pricing on Products Through AMDeC F.I.R.S.T.™ Vendor Partnership Program 2Agilent Technologies Expands Agreement to Offer AMDeC Members Preferential Pricing on Products Through AMDeC F.I.R.S.T.™ Vendor Partnership Program 3Transcription factor scan identifies genetic cause for inherited blindness 2
Request Info...
Rabbit polyclonal to Presenilin 1, prediluted ( Abpromise for all tested applications). entrezGeneID: 5663 SwissProtID: P49768...
... are designed for use with the ProQuest ... MaV203 contains deletions in the endogenous GAL4 ... two-hybrid systems. The strain also has leu2 ... bait and prey vectors. MaV203 contains three ...
Mouse monoclonal [CAT-1] to Chloramphenicol Acetyltransferase ( Abpromise for all tested applications)....
Biology Products: